FDA’s Priority Reviews May Have Helped Reduce New Drug Shortages
Executive Summary
But agency's policy changes have failed to ameliorate ongoing shortages, GAO finds.
You may also be interested in...
US FDA's Drug Shortage Effort Questioned By GAO
GAO's 'high risk' report lowers FDA grade for its drug shortage action plans, saying efforts have not been sustained.
Drug Pricing Panacea Or Just PR Victory? Expedited ANDAs May Have Limited Impact
In theory, reviewing generic applications faster should speed competition; in practice, FDA's new policy likely won't make too much difference.
FDA Drug Shortage Advice: Talk To Us Early; We’ll Be Discreet
Manufacturers shouldn’t be afraid to work with FDA on preventing drug shortages for fear of public shaming, agency says.